Reflecting on 2021 – a year of progress
As we bid farewell to another challenging year, we reflect on our work with partners and colleagues in 2021.
As we bid farewell to another challenging year, we reflect on our work with partners and colleagues in 2021.
Richard Godfrey has joined LifeArc as its first Chief Operating Officer (COO). The new role will strengthen…
Helping to progress an innovative gene therapy platform from the bench to a stage where it is progressing closer to the clinic.
Aims to transform the way diseases such as motor neurone disease are prevented, identified and treated.
An antibody-based treatment and protein-based vaccine reduced Alzheimer’s symptoms in mouse models of the disease.
This week, results from the 100,000 Genomes Project showed that whole genome sequencing improves the diagnosis of…
10 innovative start-up companies working at the interface of biomedical and data science are to receive personalised…
Reimagining the grid manufacturing process.
LifeArc and partners announce a £13 million financing deal in Closed Loop Medicine to enable the company to develop further and faster.